Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| MiMedx Group, Inc.(MDXG) | 28,195,249 | 28,195,249 | 0 | $166.63M | $271.24M | 62.61% | +$104.60M |
| Bioventus Inc.CL A(BVS) | 13,021,324 | 13,021,324 | 0 | $155.60M | $136.72M | 31.56% | -$18.88M |
| TELA Bio, Inc.(TELA) | 4,110,709 | 4,110,709 | 0 | $10.40M | $12.41M | 2.87% | +$2.01M |
| EyePoint, Inc.(EYPT) | 1,551,521 | 1,169,857 | -381,664 | $12.40M | $8.72M | 2.01% | -$3.68M |
| MediciNova, Inc.(MNOV) | 1,105,941 | 1,105,941 | 0 | $2.32M | $2.32M | 0.54% | $0 |
| Revance Therapeutics Inc | 457,085 | 457,085 | 0 | $2.37M | $1.39M | 0.32% | -$982.7K |
| Venus Concept, Inc. | 1,089,190 | 1,089,190 | 0 | $664.8K | $413.9K | 0.10% | -$250.9K |